Cargando…

Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder

OBJECTIVE: Although switching antipsychotics is a common strategy in the treatment of schizophrenia, caution is needed because of the risk of worsening of psychosis, particularly when switching to a dopamine D2 partial agonist. Homovanillic acid (HVA), a dopamine metabolite, is thought to be a possi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ichinose, Mizue, Miura, Itaru, Horikoshi, Sho, Yamamoto, Shinnosuke, Kanno-Nozaki, Keiko, Watanabe, Kenya, Yabe, Hirooki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053707/ https://www.ncbi.nlm.nih.gov/pubmed/33883897 http://dx.doi.org/10.2147/NDT.S306573

Ejemplares similares

Near-infrared spectroscopy and plasma homovanillic acid levels in bipolar disorder: a case report
por: Miura, Itaru, et al.
Publicado: (2014)

COMT Val 108/158 Met polymorphism and treatment response to aripiprazole in patients with acute schizophrenia
por: Kaneko, Haruka, et al.
Publicado: (2018)

Hashimoto encephalopathy with high plasma monoamine metabolite levels: a case report
por: Horikoshi, Sho, et al.
Publicado: (2017)

Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy
por: Miura, Itaru, et al.
Publicado: (2023)

PM446. The relationship between MMN and COMT Val108/158Met genotype in schizophrenia
por: Horikoshi, Sho, et al.
Publicado: (2016)

Antidepressive Effect of Antipsychotics in the Treatment of Schizophrenia: Meta-Regression Analysis of Randomized Placebo-Controlled Trials
por: Miura, Itaru, et al.
Publicado: (2020)

PM516. Association of DNA Methylation of Taq1A in the DRD2 with Response to Aripiprazole in acute schizophrenia
por: Miura, Itaru, et al.
Publicado: (2016)

Young patient with treatment-resistant schizophrenia drastically improved by combination of clozapine and maintenance electroconvulsive therapy: a case report
por: Ito, Masashi, et al.
Publicado: (2019)

The efficacy of antipsychotics for prolonged delirium with renal dysfunction
por: Asano, Satoko, et al.
Publicado: (2017)

Effects of Atypical Antipsychotics, Clozapine, Quetiapine and Brexpiprazole on Astroglial Transmission Associated with Connexin43
por: Fukuyama, Kouji, et al.
Publicado: (2021)

Opposing effects of clozapine and brexpiprazole on β-aminoisobutyric acid: Pathophysiology of antipsychotics-induced weight gain
por: Fukuyama, Kouji, et al.
Publicado: (2023)

Newer antipsychotics: Brexpiprazole, cariprazine, and lumateperone: A pledge or another unkept promise?
por: Barman, Rajdip, et al.
Publicado: (2021)

New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin
por: Caraci, Filippo, et al.
Publicado: (2020)

Effect of Supplementation on Levels of Homovanillic and Vanillylmandelic Acids in Children with Autism Spectrum Disorders
por: Gątarek, Paulina, et al.
Publicado: (2022)

HETEROGENEITY IN PLASMA HOMOVANILLIC ACID LEVELS IN SCHIZOPHRENIFORM DISORDER
por: Pradhan, N., et al.
Publicado: (1992)

The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors
por: Hardy, Rachel E., et al.
Publicado: (2023)

Monitoring side-effects of antipsychotics using the glasgow antipsychotic side-effect scale
por: Sterritt, James
Publicado: (2021)

Electroconvulsive Therapy for Parkinson’s Disease with Depression and Neuroleptic Malignant Syndrome: A Case Report
por: Mori, Yuhei, et al.
Publicado: (2021)

CONCENTRATIONS OF HOMOVANILLIC ACID AND GONADAL HORMONES IN THE SERUM OF MALE SCHIZOPHRENIC PATIENTS
por: Gong, S.L., et al.
Publicado: (1993)

Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
por: Goto, Ryoji, et al.
Publicado: (2023)

Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder
por: Azekawa, Takaharu, et al.
Publicado: (2011)

Pharmacogenetics of antipsychotic-induced side effects
por: Lencz, Todd, et al.
Publicado: (2009)

Clinical role of brexpiprazole in depression and schizophrenia
por: Parikh, Nishant B, et al.
Publicado: (2017)

Impressive Response with Brexpiprazole in Ekbom’s syndrome
por: Hsiao, J., et al.
Publicado: (2022)

Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study
por: Citrome, Leslie, et al.
Publicado: (2013)

The effect of brexpiprazole in adult outpatients with early-episode schizophrenia: an exploratory study
por: Malla, Ashok, et al.
Publicado: (2016)

Effect of Brexpiprazole on Prolactin: An Analysis of Short- and Long-Term Studies in Schizophrenia
por: Ivkovic, Jelena, et al.
Publicado: (2019)

Treatment Discontinuation Among Patients with Schizophrenia Treated with Brexpiprazole and Other Oral Atypical Antipsychotics in Japan: A Retrospective Observational Study
por: Hishimoto, Akitoyo, et al.
Publicado: (2022)

What side effects are problematic for patients prescribed antipsychotic medication? The Maudsley Side Effects (MSE) measure for antipsychotic medication
por: Wykes, T., et al.
Publicado: (2017)

Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report
por: Tucker, Murray G., et al.
Publicado: (2016)

Treatment Patterns and Antipsychotic Medication Adherence Among Commercially Insured Patients With Schizoaffective Disorder in the United States
por: Joshi, Kruti, et al.
Publicado: (2016)

Analysis of the effect of brexpiprazole on sleep architecture in patients with schizophrenia: A preliminary study
por: Arai, Yusuke, et al.
Publicado: (2023)

Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial
por: Huhn, Maximilian, et al.
Publicado: (2020)

Switching Between Second-Generation Antipsychotics in Patients with Schizophrenia and Schizoaffective Disorder: 10-Year Cohort Study in Brazil
por: Fulone, Izabela, et al.
Publicado: (2021)

A Modified Fluorimetric Method for Determination of Hydrogen Peroxide Using Homovanillic Acid Oxidation Principle
por: Paital, Biswaranjan
Publicado: (2014)

Voltammetric Detection of Vanillylmandelic Acid and Homovanillic Acid Using Urea-Derivative-Modified Graphite Electrode
por: Shishkanova, Tatiana V., et al.
Publicado: (2023)

Sex differences in antipsychotic efficacy and side effects in psychosis
por: Erzin, G.
Publicado: (2023)

Continuation rate for asenapine and brexpiprazole treatment in patients with schizophrenia
por: Inoue, Yuichi, et al.
Publicado: (2021)

Brexpiprazole—Pharmacologic Properties and Use in Schizophrenia and Mood Disorders
por: Siwek, Marcin, et al.
Publicado: (2023)

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
por: Sajatovic, Martha, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kk1ovdneb751kmdso7jr86rha7